Opexa Therapeutics CEO to Present at the 2014 Leerink Global Healthcare Conference

[Business Wire] – Opexa Therapeutics, Inc. , a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis , today announced that Neil K. more

View todays social media effects on OPXA

View the latest stocks trending across Twitter. Click to view dashboard

See who Opexa is hiring next, click here to view